Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Lilly launches Xigris in E.U. for severe sepsis

Oct. 31, 2002

Abbott reveals novel alphavbeta3 modulators in recent patent

Oct. 31, 2002

NCX-4016 IND cleared for phase II

Oct. 25, 2002

License agreement for Collagenex's IMPACS compounds for aortic aneurysms

Oct. 25, 2002

Phase III trial of tecadenoson in PSVT meets primary endpoint

Oct. 25, 2002

Chronic NCX-4016 attenuates development of atherosclerosis in mouse model

Oct. 24, 2002

Top-line results from phase IIb/III sitaxsentan trial

Oct. 23, 2002

PDE5 inhibitor T-1032 effective in hamster model of chronic heart failure

Oct. 22, 2002

Aventis presents new upregulators of eNOS expression

Oct. 22, 2002

Novel inhibitors of neutral sphingomyelinase in early development at Ono

Oct. 22, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy
BioWorld
Eli Lilly and Co. plans to buy Centessa Pharmaceuticals plc for $6.3 billion in up-front cash and another potential $1.5 billion through contingent value rights,...